Infectious cell culture supernatant. This Lassa virus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been sequenced.
Infectious cell culture supernatant. This Lassa virus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been sequenced.
Infectious cell culture supernatant. This Lassa virus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been sequenced.
Infectious cell culture supernatant. This Lassa virus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been sequenced.
Infectious cell culture supernatant. This Lassa virus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been sequenced.
Infectious cell culture supernatant. This Lassa virus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been sequenced.
Infectious cell culture supernatant. This Lassa virus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been sequenced.
Infectious cell culture supernatant. This Lassa virus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been sequenced.
Infectious cell culture supernatant containing SARS-Cov-2 (strain human/DEU/HH-1/2020). This strain is preserved under Viral Storage Medium -80C. To confirm its identity the virus has been completely sequenced
